Upstream Bio (UPB) Other Operating Expenses (2024 - 2026)
Upstream Bio (UPB) posted quarterly Other Operating Expenses of -$1.1 million for Q1 2026, down 5.6% year-over-year from -$1.2 million in Q1 2025, and up 14.97% quarter-over-quarter from -$1.3 million in Q4 2025.
Upstream Bio (UPB) Other Operating Expenses (2024 - 2026) Analysis & Trends
Upstream Bio's Other Operating Expenses history runs 3 years deep, the most recent figure standing at -$1.1 million for Q1 2026.
- In Q1 2026, Other Operating Expenses fell 5.6% year-over-year to -$1.1 million; the TTM figure through Mar 2026 stood at -$4.6 million (down 77.37% YoY), while the FY2025 annual figure was -$4.5 million, down 127.77% from the prior year.
- Other Operating Expenses for Q1 2026 stood at -$1.1 million, up from -$1.3 million in the prior quarter.
- The five-year high for Other Operating Expenses was -$334000.0 in Q2 2024, with the low at -$1.3 million in Q4 2025.
- The 3-year median for Other Operating Expenses is -$891000.0 (2025), against an average of -$843666.7.
- The sharpest annual moves came in 2025 and 2026: Other Operating Expenses tumbled 273.95% in 2025, then dropped 5.6% in 2026.
- Upstream Bio's Other Operating Expenses stood at -$836000.0 in 2024, then tumbled by 56.58% to -$1.3 million in 2025, then climbed by 14.97% to -$1.1 million in 2026.
- Business Quant data shows UPB's Other Operating Expenses at -$1.1 million in Q1 2026, -$1.3 million in Q4 2025, and -$891000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Upstream Bio | 387.23 Mn | 387.23 Mn | -3.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.19 Mn |
| Mar 31, 2026 | -1.11 Mn |
| Dec 31, 2025 | -1.31 Mn |
| Sep 30, 2025 | -891,000.00 |
| Jun 30, 2025 | -1.25 Mn |
| Mar 31, 2025 | -1.05 Mn |
| Dec 31, 2024 | -836,000.00 |
| Sep 30, 2024 | -348,000.00 |
| Jun 30, 2024 | -334,000.00 |
| Mar 31, 2024 | -459,000.00 |